- Home
- XFOR vs OFLX Comparison
XFOR vs OFLX Comparison
Compare XFOR & OFLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XFOR | OFLX |
|---|---|---|
| Founded | 2014 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.5M | 294.7M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | XFOR | OFLX |
|---|---|---|
| Price | $3.76 | $33.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $28.50 | N/A |
| AVG Volume (30 Days) | ★ 475.3K | 41.2K |
| Earning Date | 11-05-2025 | 03-04-2026 |
| Dividend Yield | N/A | ★ 4.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.59 |
| Revenue | $33,979,000.00 | ★ $100,054,000.00 |
| Revenue This Year | $1,266.01 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.75 |
| Revenue Growth | ★ 2925.74 | N/A |
| 52 Week Low | $1.35 | $25.58 |
| 52 Week High | $24.43 | $43.18 |
Technical Indicators
Market Signals| Indicator | XFOR | OFLX |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 71.59 |
| Support Level | $3.57 | $31.51 |
| Resistance Level | $3.78 | $32.99 |
| Average True Range (ATR) | 0.20 | 1.21 |
| MACD | -0.04 | 0.22 |
| Stochastic Oscillator | 27.94 | 93.63 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.